A Multi-Site RCT of a Stepped-Care Intervention for Emergency Department Patients With Panic Attacks and Panic Disorder

NCT03632356 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2023-12-21

No results posted yet for this study

Summary

Using a randomized controlled trial (RCT) design, the main objective of this study is to evaluate the clinical, patient-centered, and economic effectiveness of a stepped-care intervention for patients with panic attacks and panic disorder presenting to the busiest Accident and Emergency (A\&E) departments of the largest public healthcare group in Singapore.

The RCT will have two arms: 1) treatment via an enhanced care pathway consisting of a stepped-care intervention for panic attacks and panic disorder; and 2) a control arm consisting of screening for panic attacks and panic disorder in the A\&E and discharge (routine care). In addition to the baseline assessment, the study follow-up visits will occur at 1, 3, 6, and 12 months.

Conditions

  • Panic Attacks and Disorders

Interventions

BEHAVIORAL

Stepped Care Intervention (STEP)

A stepwise progression of intervention according to the participant's response to the increasing levels of therapy. There will be 1 session of psychoeducation, followed by 5 sessions of Cognitive Behavioral Therapy (CBT) if panic symptoms do not improve at 1-month follow-up.

DIAGNOSTIC_TEST

Screening only

Screening for probable panic attacks or panic disorder using the Structured Clinical Interview for DSM-5

Sponsors & Collaborators

  • Duke-NUS Graduate Medical School

    collaborator OTHER
  • Changi General Hospital

    collaborator OTHER
  • National Medical Research Council (NMRC), Singapore

    collaborator OTHER_GOV
  • Singapore General Hospital

    lead OTHER

Principal Investigators

  • Sharon C Sung, PhD · Duke-NUS Graduate Medical School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-11
Primary Completion
2024-05-31
Completion
2024-11-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03632356 on ClinicalTrials.gov